Concentrations of d,l-methadone were determined in blood samples from people arrested for driving under the influence of drugs (DUID), users of illicit drugs, and methadone-related deaths. In drug overdose deaths (N 5 346), mean (median) and highest concentrations of methadone in femoral blood were 0.53 mg/L (0.40 mg/L) and 6.7 mg/L, compared with 0.46 mg/L (0.30 mg/L) and 3.7 mg/L in non-poisoning deaths (N 5 157) ( p < 0.05). In DUID suspects and users of illicit drugs (N 5 909), the bloodmethadone concentrations were much lower, 0.23 mg/L (0.20 mg/L) and 1.1 mg/L (p < 0.001). The median concentration of methadone in blood decreased as the number of coingested drugs increased in the overdose deaths: 0.5 mg/L with methadone the only drug compared with 0.2 mg/L with 6 -9 other drugs present ( p < 0.001). These coingested drugs were mainly benzodiazepines (diazepam, alprazolam, flunitrazepam) and amphetamines; THC and morphine (from heroin) were the major illicit drugs. The overlap in blood-methadone concentrations in living cases and autopsy cases makes it difficult to conclude that methadone overdose was the cause of death. Adverse drug-drug interactions and varying degrees of tolerance to opiates complicate the interpretation.
Introduction
Methadone was synthesized in the early 1940s in Germany, although this narcotic analgesic did not hit the headlines internationally until 1965 when Dole and Nyswander (1) described the use of methadone maintenance treatment (MMT) for the rehabilitation of heroin addicts (1, 2) . MMT represented a paradigm shift in pharmacotherapy for heroin addiction and substitution programs began to spread around the world and are prominent still today (3) . The strategy of substituting a licit drug (methadone) for an illicit drug (heroin) marked a turning point in the rehabilitation of heroin addicts, many of whom were able to live normal lives, albeit with daily intake of methadone (4, 5) .
Like morphine, methadone is an agonist at the m-opiate receptor, but its longer elimination half-life and improved oral bioavailability make it an attractive alternative for pain medication as well as MMT programs (6, 7) . Although supervised intake of methadone was once the norm for use in treating heroin addicts, the recent popularity of methadone as a pain medication has led to people taking the medication home for self-administration (7, 8) . The less restrictive prescribing of methadone for pain management has had negative consequences, such as diversion from legitimate use to recreational use and abuse (9) (10) (11) . Admission to hospital for treatment of methadone poisoning has increased appreciably along with a high prevalence of methadone-related overdose deaths in many nations (12 -14) .
The aim of the present study was to compare and contrast the concentrations of d,l-methadone in femoral blood in methadone-related deaths with the concentrations determined in venous blood from apprehended drivers (DUID) and people arrested on the streets for use of illicit drugs. In addition, the demographics of people using methadone, the prevalence and concentrations of various coingested drugs were also evaluated in the living and the dead.
Materials and Methods

Forensic toxicology in Sweden
Forensic toxicology in Sweden ( population 9.3 million) is centralized to a single accredited laboratory that receives biological specimens for analysis from the living and the dead. Forensic autopsies are performed at six university teaching hospitals located in Lund, Gothenburg, Uppsala, Stockholm, Linko¨ping, and Umea˚. The local police authorities request a forensic autopsy whenever an unnatural or suspicious out-of-hospital death is investigated. Blood and urine samples from people arrested by the police suspected of driving under the influence of alcohol or drugs or for using illicit drugs are also sent to the same central toxicology laboratory.
This retrospective study was done with the help of an in-house database (TOXBASE) that we searched for forensic cases in which methadone was verified present in peripheral blood samples. The period studied was 2000 -2010 because over this time, the method used for qualitative and quantitative analysis of methadone in blood has remained unchanged. We recorded information about the age and sex of those taking methadone, the concentrations in blood, the types and concentrations of co-administered drugs, the manner of death according to the medical examiner reports, and whether drug poisoning or other (trauma, natural) was also related to the concentration of methadone in blood.
Biological specimens
Forensic pathologists in Sweden are required, whenever possible, to submit femoral blood for toxicological analysis after adding potassium fluoride (1 -2%) as a preservative. If circumstances of the death precluded obtaining femoral blood (e.g., because of extensive trauma or if the body was decomposed), these cases were omitted from the present study. In apprehended drivers and also in people arrested for use of illicit drugs, venous blood is taken from a cubital vein into evacuated grey-stopper tubes containing a mixture of potassium oxalate and sodium fluoride (1%) as preservatives.
The material for this study comprised N ¼ 503 autopsy cases involving methadone-related deaths, N ¼ 594 individuals suspected for driving under the influence of drugs, and N ¼ 315 people suspected for use of illicit drugs.
Toxicological analysis
The analytical toxicology starts with an initial screening analysis for drugs of abuse using a specimen of urine if available, and using blood after protein precipitation if not. Immunoassay (EMIT or CEDIA) serves to select presumptive positive cases that are then verified by more specific chromatographic methods. Ethanol was determined in blood by headspace gas chromatography (GC) with a well-established method, and results were reported positive if the concentration exceeded an analytical cutoff of 0.2 g/L (0.02 g/100 mL).
Illicit drugs are analyzed by gas chromatography -mass spectrometry (GC -MS) with deuterium-labeled internal standards. Prescription drugs (e.g., benzodiazepines) and methadone were analyzed in whole blood after solvent extraction and capillary column GC with a nitrogen-phosphorus detector. This analytical method allowed quantitative analysis of about 200 different weakly acidic, neutral, and basic drugs as well as many metabolites. The analytical limit of quantitation for reporting presence of methadone in blood was 0.05 mg/L for samples from the living and 0.1 mg/L for autopsy specimens.
Statistical analysis
Means, medians, standard deviations (SD), and upper 90th, 95th, and 97.5th percentiles were used as descriptive statistics. Two mean values (e.g., mean age in men and women) were compared by Student's independent t-test. Two medians were compared by Mann-Whitney test for unpaired data, and proportions of males to females were compared by a chi-squared test. Results were considered statistically significant if p , 0.05. Figure 1 shows the increases in number of forensic cases (living and dead) in which methadone was verified present in blood samples submitted for forensic toxicology over an 11-year period. The increase in number of methadone cases was most apparent in the methadone-related deaths.
Results
Development in methadone cases
Age, sex, and concentration of methadone in blood The proportion of male to female methadone users was 90% versus 10% in DUID suspects and users of illicit drugs, compared to 83% versus 17% in autopsy cases (Table I ). The average age of methadone users was about the same in men and women ( p . 0.05), whereas the overall age of methadone users was 37 + 10 years. Table I shows that victims of a methadone-related poisoning death were younger (36 + 11.5 y, N ¼ 346) compared with other causes of death in methadone users (41 + 13.3 y, N ¼ 157) (p , 0.001). Figure 2 compares the relative frequency distributions of age of methadone users in autopsy cases and living cases (DUID suspects and users of illicit drugs). The ages spanned from ,20 years to .75 years, and the vast majority was between 25 and 45 years.
The median concentration of methadone in blood was higher in poisoning deaths (0.4 mg/L) compared with other causes of death in methadone users (0.3 mg/L), and the autopsy material had higher concentrations than the DUID suspects and the users of illicit drugs (0.2 mg/L) ( Table I ). The box and whiskers plot in Figure 3 indicates good agreement between the concentration distributions of methadone in DUID suspects and users of illicit drug, whereas means and medians were significantly higher in autopsy cases, the latter also having more extreme outlying values.
Fluctuations in median concentrations of methadone over the 11-year study period can be seen from Figure 4 , which shows all living cases (N ¼ 909) and autopsy cases (N ¼ 346) when drug poisoning was given on the death certificate. The medians were always higher in the autopsy cases except for one year (2005) when they were the same (Figure 4) .
Relative frequency distributions of blood-methadone concentrations in living cases and poisoning deaths are compared in Figure 5 . Use of a higher cutoff concentration for reporting methadone positive results in autopsy cases explains the absence of a bar under 0.1 mg/L. The concentration of methadone in blood exceeded 1.0 mg/L in only 2 living cases (0.2%) compared with 46 (13%) autopsy cases. Furthermore, there were 41% of autopsy cases with blood methadone .0.50 mg/L compared with 9.7% of the living cases (p , 0.001). Table II presents mean age, proportion of men to women and the median concentrations of methadone in blood in the autopsy cases in relation to the number of other drugs identified in the blood samples. The median concentration of methadone decreased from 0.5 mg/L (mono-drug deaths) to 0.2 mg/ L (6 -9 drugs), which is a statistically significant difference ( p , 0.001).
Drugs coingested with methadone in autopsy cases
Table II also shows the proportion of deaths classified by medical examiners as a drug poisoning or some other cause (e.g., trauma, natural) in relation to number of coingested drugs. In the mono-drug deaths (methadone only), 52% were poisonings and 48% were attributed to other causes ( p . 0.05). As the number of coingested drugs increased, about 70 -80% of the deaths were attributed to poisoning, whereas only 20 -30% were ascribed to other causes ( p , 0.001).
The drugs most often identified in blood along with methadone are listed in Table III showing a predominance of benzodiazepines (diazepam, alprazolam, and clonazepam) and the major illicit drugs were cannabis, amphetamine, and morphine (mainly from heroin). The median concentration of methadone in blood varied from 0.3 to 0.5 mg/L depending on the types of coingested drugs. (Table V) . Benzodiazepines were still highly prevalent, especially alprazolam, diazepam, and flunitrazepam; cannabis, amphetamine, and morphine (from heroin) were the major illicit drugs. The median concentration of methadone in blood varied from 0.1 to 0.3 mg/L depending on the types of other drugs identified in blood.
Drugs coingested with methadone in living cases
Discussion
The use of methadone as pharmacotherapy for rehabilitation of heroin addicts has had many proponents and critics since the seminal publications by Dole and Nyswander (15, 16) . Methadone is a synthetic opioid, both historically and structurally related to pethidine, with both substances possessing analgesic and spasmolytic properties (17) . These drugs have potential for abuse and have been implicated in many overdose deaths and admissions to hospital emergency departments for life-saving treatment (8, 18) . Many of the methadone-related fatalities in our study were previously registered for drug-related offences; 69% (N ¼ 346) among poisoning deaths compared with 59% (N ¼ 157) when some other cause of death was given by the medical examiner.
Care is needed when methadone is prescribed for the first time to opiate-naive individuals for MMT and in pain management programs (19, 20) . The potential for diversion and abuse of methadone is lower if the drug is administered under supervision, such as was often done at outpatient clinics (21) . The upsurge of take-home methadone for MMT and pain management has had negative consequences, including diversion from the licit to the illicit drug market and this is considered a key factor in many methadone-related deaths and drug overdose treatment (9) .
The method of analysis used in our laboratory cannot distinguish between the two optical isomers of methadone, so the concentrations reported here are for the racemate d,lmethadone. Some laboratories analyze the R-and S-forms of methadone separately, because these isomers have a different pharmacokinetic profile, including half-life and volume of distribution (22, 23) . The analgesic effect of methadone resides in the R-form, whereas the S-form has been incriminated in potentially fatal cardiovascular events by prolonging the so-called QT-interval (24, 25) . Prescribing a pharmaceutical product consisting essentially of the R-isomer of methadone (e.g., for pain management or for MMT) might reduce mortality associated with the S-isomer (26) . Others have suggested that polymorphism in the enzymes responsible for hepatic metabolism of methadone CYP3A4, CYP2B6, or CYP2D6 may play a role in methadone toxicity and methadone-related deaths (27 -29) .
In an autopsy study involving the analysis of methadone in blood from left and right femoral veins, Linnet et al. (30) demonstrated that analytical variation was negligible compared with sampling site variation. This suggests that more efforts are needed to reduce sources of pre-analytical variation in postmortem toxicology. Methadone is a drug with a fairly large volume of distribution (3.6 -5 L/kg), which makes it prone to -MAM (heroin use) was present in blood, and morphine concentration was 0.08 mg/L (median) and methadone 0.10 mg/L. In 172 cases, 6-MAM was negative in blood, and morphine concentration was 0.03 mg/L (median) and blood methadone 0.10 mg/L. † Amphetamine and/or methamphetamine. redistribute from tissue compartments into central blood after death. In one study, the mean (median) concentration in heart blood was 0.57 mg/L (0.56 mg/L) compared with 0.72 mg/L (0.55 mg/L) for an alternative sampling site, mainly subclavian blood (31) . Femoral blood is the preferred specimen for analysis in postmortem toxicology because redistribution artifacts are minimized, making results somewhat easier to interpret. In the present study, median concentration of methadone was significantly higher ( p , 0.001) in autopsy cases compared with living cases, although there was a considerable overlap in the frequency distributions ( Figure 5 ). There were also more extreme values in the autopsy material, as expected in drug overdose deaths, with 41% above 0.50 mg/L compared with only 9.7% above this concentration in the living cases. Table VI presents the results of a literature search into the concentrations of methadone reported in postmortem blood under different circumstances. Because of the skewed concentration distributions it is more valid to compare and contrast medians rather than means. When an article presented methadone concentrations in individual cases, the mean and median values were calculated by us. Unfortunately, in some articles, the site used to sample blood was not mentioned, so the concentrations reported in Table VI probably reflect both central and peripheral blood compartments.
Milroy and Forrest (32) reported that, in 50 adult poisoning deaths involving methadone, the median concentration was 0.435 mg/L, compared with 0.294 mg/L when the death was ascribed to a combination of methadone and other drugs (N ¼ 56). In the same study, large differences, up to 100%, were noted for the concentrations of methadone determined in blood from peripheral and central sampling sites. This underscores the need to report blood-sampling site when postmortem drug concentrations are compared and contrasted. Seymour et al. (33) reported a higher median concentrations in single-drug methadone deaths (median 0.7 mg/L) compared with mixed-drug deaths (median 0.3 mg/L). In many of the drug poisoning deaths, an elevated concentration of methadone was simply an incidental finding and the coingested drugs were primarily responsible for the death. In cases when methadone was the only drug identified in blood (median concentration 0.5 mg/L) 52% of deaths were classified as drug poisoning whereas 48% had other causes ( p . 0.05).
In a Norwegian study of DUID suspects (34), the median (and range) of blood-methadone concentrations was 0. (34) . Each DUID suspect was examined by a physician, who looked for signs and symptoms of drug influence, although there was no significant correlation between the concentration of methadone in blood and the conclusion from the clinical examination (impaired or not impaired). Neither the Norwegian study nor the present study could be used to tell how many DUID suspects, if any, required medical intervention for drug overdose.
The daily dose of methadone for effective relief of pain or to counteract withdrawal in heroin addicts seems to differ widely between different patients, making it important to titrate the dose to the required clinical effect (35, 36) . In this connection, the starting dose should be carefully selected to avoid adverse effects such as acute opiate toxicity (37) . A very high daily dose of methadone was necessary to achieve a clinical effect in a person exhibiting polymorphism in the CYP450 enzyme and who was genotyped as an ultra rapid metabolizer (38) . In MMT programs, the plasma concentrations of methadone usually range from about 0.25 mg/L to 0.50 mg/L and accordingly are close to the median values observed in methadone-related deaths shown in Table VI (39, 40) . As emphasized elsewhere (41) , in postmortem toxicology, valid and relevant information for the pathologists would be to report whether the concentration of a certain drug was low, average, or high compared with past experiences from the same laboratory and the same type of blood sample with the same analytical method.
In conclusion, this study demonstrates an appreciable overlap in the concentrations of d,l-methadone in peripheral blood from the living and the dead. This complicates the interpretation of blood-methadone concentrations in autopsy cases because knowledge about the individual's tolerance to opiates is mostly lacking. Moreover, a high prevalence of poly-drug use in methadone users increases the potential for an adverse drugdrug interaction and at the same time heightening the risk of acute toxicity. 
